NASDAQ Composite opens in less than three hours and Catalyst Pharmaceuticals’s premarket value is already 1.75% down.
The last session, nASDAQ Composite finished with Catalyst Pharmaceuticals jumping 1.48% to $3.42. NASDAQ Composite rose 0.15% to $12,870.00, following last session’s upward trend on what was a somewhat positive trend exchanging session.
Catalyst Pharmaceuticals’s last close was $3.42, 54.39% under its 52-week high of $5.28.
Catalyst Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.
Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a positive 1.48%, a negative 0.00%, and a negative 0.33%, respectively.
Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 3.60%, 3.74%, and 4.97%, respectively.